perfect- as i rather suspected. Looking at the slides featuring plots that list out the comparison studies virtually all those studies use chemo therapies that are either unheard of, not used in this cancer or just single gemcitabine alone!! So obviously panco with its use of background chemo known to be current best ( folfirox or gemcitanine plus abraxane) will show statistically better outcome. Doesn’t prove added benefit of device. If anything it could just point to confirming the better chemo used in panco really is better. Bizarre.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |